• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无标记蛋白质组学鉴定内源性、胰岛素刺激的胰岛素受体底物-1 的相互作用伙伴。

Label-free proteomic identification of endogenous, insulin-stimulated interaction partners of insulin receptor substrate-1.

机构信息

Center for Metabolic and Vascular Biology, Arizona State University, Tempe, AZ, USA.

出版信息

J Am Soc Mass Spectrom. 2011 Mar;22(3):457-66. doi: 10.1007/s13361-010-0051-2. Epub 2011 Jan 29.

DOI:10.1007/s13361-010-0051-2
PMID:21472564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3072570/
Abstract

Protein-protein interactions are key to most cellular processes. Tandem mass spectrometry (MS/MS)-based proteomics combined with co-immunoprecipitation (CO-IP) has emerged as a powerful approach for studying protein complexes. However, a majority of systematic proteomics studies on protein-protein interactions involve the use of protein overexpression and/or epitope-tagged bait proteins, which might affect binding stoichiometry and lead to higher false positives. Here, we report an application of a straightforward, label-free CO-IP-MS/MS method, without the use of protein overexpression or protein tags, to the investigation of changes in the abundance of endogenous proteins associated with a bait protein, which is in this case insulin receptor substrate-1 (IRS-1), under basal and insulin stimulated conditions. IRS-1 plays a central role in the insulin signaling cascade. Defects in the protein-protein interactions involving IRS-1 may lead to the development of insulin resistance and type 2 diabetes. HPLC-ESI-MS/MS analyses identified eleven novel endogenous insulin-stimulated IRS-1 interaction partners in L6 myotubes reproducibly, including proteins play an important role in protein dephosphorylation [protein phosphatase 1 regulatory subunit 12A, (PPP1R12A)], muscle contraction and actin cytoskeleton rearrangement, endoplasmic reticulum stress, and protein folding, as well as protein synthesis. This novel application of label-free CO-IP-MS/MS quantification to assess endogenous interaction partners of a specific protein will prove useful for understanding how various cell stimuli regulate insulin signal transduction.

摘要

蛋白质-蛋白质相互作用是大多数细胞过程的关键。基于串联质谱(MS/MS)的蛋白质组学结合免疫共沉淀(CO-IP)已成为研究蛋白质复合物的有力方法。然而,大多数关于蛋白质-蛋白质相互作用的系统蛋白质组学研究都涉及使用蛋白质过表达和/或表位标记诱饵蛋白,这可能会影响结合化学计量,并导致更高的假阳性。在这里,我们报告了一种简单的、无标签的 CO-IP-MS/MS 方法的应用,该方法不使用蛋白质过表达或蛋白质标签,来研究在基础和胰岛素刺激条件下,与诱饵蛋白(在这种情况下是胰岛素受体底物-1(IRS-1))相关的内源性蛋白质丰度的变化。IRS-1 在胰岛素信号级联中起着核心作用。涉及 IRS-1 的蛋白质-蛋白质相互作用的缺陷可能导致胰岛素抵抗和 2 型糖尿病的发展。HPLC-ESI-MS/MS 分析在 L6 肌管中可重复性地鉴定出十一种新的内源性胰岛素刺激的 IRS-1 相互作用伙伴,包括在蛋白质去磷酸化[蛋白磷酸酶 1 调节亚基 12A(PPP1R12A)]、肌肉收缩和肌动蛋白细胞骨架重排、内质网应激和蛋白质折叠以及蛋白质合成中起重要作用的蛋白质。这种无标签 CO-IP-MS/MS 定量方法用于评估特定蛋白质的内源性相互作用伙伴的新应用将有助于理解各种细胞刺激如何调节胰岛素信号转导。

相似文献

1
Label-free proteomic identification of endogenous, insulin-stimulated interaction partners of insulin receptor substrate-1.无标记蛋白质组学鉴定内源性、胰岛素刺激的胰岛素受体底物-1 的相互作用伙伴。
J Am Soc Mass Spectrom. 2011 Mar;22(3):457-66. doi: 10.1007/s13361-010-0051-2. Epub 2011 Jan 29.
2
Label-free relative quantification of co-eluting isobaric phosphopeptides of insulin receptor substrate-1 by HPLC-ESI-MS/MS.高效液相色谱-电喷雾串联质谱法对胰岛素受体底物-1共洗脱等摩尔磷酸肽的无标记相对定量。
J Am Soc Mass Spectrom. 2010 Sep;21(9):1490-9. doi: 10.1016/j.jasms.2010.05.009. Epub 2010 Jun 9.
3
Quantification of phosphorylation of insulin receptor substrate-1 by HPLC-ESI-MS/MS.通过高效液相色谱-电喷雾串联质谱法对胰岛素受体底物-1的磷酸化进行定量分析。
J Am Soc Mass Spectrom. 2006 Apr;17(4):562-567. doi: 10.1016/j.jasms.2005.12.010. Epub 2006 Feb 28.
4
Global IRS-1 phosphorylation analysis in insulin resistance.胰岛素抵抗中的全球 IRS-1 磷酸化分析。
Diabetologia. 2011 Nov;54(11):2878-89. doi: 10.1007/s00125-011-2271-9. Epub 2011 Aug 18.
5
Protein phosphatase 1 regulatory subunit 12A and catalytic subunit δ, new members in the phosphatidylinositide 3 kinase insulin-signaling pathway.蛋白磷酸酶 1 调节亚基 12A 和催化亚基 δ,是磷脂酰肌醇 3 激酶胰岛素信号通路的新成员。
J Endocrinol. 2012 Sep;214(3):437-43. doi: 10.1530/JOE-12-0145. Epub 2012 Jun 22.
6
Quantitative phosphoproteomics reveals novel phosphorylation events in insulin signaling regulated by protein phosphatase 1 regulatory subunit 12A.定量磷酸化蛋白质组学揭示了由蛋白磷酸酶1调节亚基12A调控的胰岛素信号传导中的新型磷酸化事件。
J Proteomics. 2014 Sep 23;109:63-75. doi: 10.1016/j.jprot.2014.06.010. Epub 2014 Jun 25.
7
Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223.利用质谱分析鉴定胰岛素受体底物1的丝氨酸/苏氨酸磷酸化位点:丝氨酸1223的调节作用
Endocrinology. 2005 Oct;146(10):4410-6. doi: 10.1210/en.2005-0260. Epub 2005 Jul 14.
8
The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2.胰岛素受体家族及其底物IRS-1和IRS-2的磷酸酪氨酸相互作用组。
Mol Cell Proteomics. 2009 Mar;8(3):519-34. doi: 10.1074/mcp.M800407-MCP200. Epub 2008 Nov 11.
9
Characterization of a Protein Interactome by Co-Immunoprecipitation and Shotgun Mass Spectrometry.通过免疫共沉淀和鸟枪法质谱对蛋白质相互作用组进行表征
Methods Mol Biol. 2017;1546:223-234. doi: 10.1007/978-1-4939-6730-8_19.
10
Quantitative proteomics reveals novel protein interaction partners of PP2A catalytic subunit in pancreatic β-cells.定量蛋白质组学揭示了胰腺β细胞中PP2A催化亚基的新型蛋白质相互作用伙伴。
Mol Cell Endocrinol. 2016 Mar 15;424:1-11. doi: 10.1016/j.mce.2016.01.008. Epub 2016 Jan 9.

引用本文的文献

1
Identification of PP1c-PPP1R12A Substrates Using Kinase-Catalyzed Biotinylation to Identify Phosphatase Substrates.利用激酶催化生物素化鉴定磷酸酶底物来鉴定PP1c-PPP1R12A底物。
ACS Omega. 2023 Sep 21;8(39):35628-35637. doi: 10.1021/acsomega.3c01944. eCollection 2023 Oct 3.
2
Quantitative Proteomics Reveals Transforming Growth Factor β Receptor Targeted by Resveratrol and Hesperetin Coformulation in Endothelial Cells.定量蛋白质组学揭示白藜芦醇与橙皮素联合制剂在内皮细胞中靶向的转化生长因子β受体
ACS Omega. 2023 Apr 25;8(18):16206-16217. doi: 10.1021/acsomega.3c00678. eCollection 2023 May 9.
3
Effect of Insulin and Pioglitazone on Protein Phosphatase 2A Interaction Partners in Primary Human Skeletal Muscle Cells Derived from Obese Insulin-Resistant Participants.胰岛素和吡格列酮对源自肥胖胰岛素抵抗参与者的原代人骨骼肌细胞中蛋白磷酸酶2A相互作用伙伴的影响。
ACS Omega. 2022 Nov 15;7(47):42763-42773. doi: 10.1021/acsomega.2c04473. eCollection 2022 Nov 29.
4
TSP50 promotes hepatocyte proliferation and tumour formation by activating glucose-6-phosphate dehydrogenase (G6PD).TSP50 通过激活葡萄糖-6-磷酸脱氢酶(G6PD)促进肝细胞增殖和肿瘤形成。
Cell Prolif. 2021 Apr;54(4):e13015. doi: 10.1111/cpr.13015. Epub 2021 Feb 25.
5
β-catenin regulates muscle glucose transport via actin remodelling and M-cadherin binding.β-catenin 通过肌动蛋白重塑和 M-钙黏蛋白结合调节肌肉葡萄糖转运。
Mol Metab. 2020 Dec;42:101091. doi: 10.1016/j.molmet.2020.101091. Epub 2020 Oct 1.
6
Potential roles of PP2A-Rac1 signaling axis in pancreatic β-cell dysfunction under metabolic stress: Progress and promise.代谢应激下 PP2A-Rac1 信号轴在胰岛β细胞功能障碍中的潜在作用:进展与展望。
Biochem Pharmacol. 2020 Oct;180:114138. doi: 10.1016/j.bcp.2020.114138. Epub 2020 Jul 4.
7
Three Novel Mutations I65S, R66S, and G86R Divulge Significant Conformational Variations in the PTB Domain of the IRS1 Gene.三种新型突变I65S、R66S和G86R揭示了IRS1基因PTB结构域中显著的构象变化。
ACS Omega. 2019 Jan 29;4(1):2217-2224. doi: 10.1021/acsomega.8b01712. eCollection 2019 Jan 31.
8
Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder.双相障碍中的骨骼肌 DNA 甲基化修饰和精神药理学治疗。
Eur Neuropsychopharmacol. 2019 Dec;29(12):1365-1373. doi: 10.1016/j.euroneuro.2019.10.001. Epub 2019 Oct 19.
9
Quantitative proteomics reveals novel interaction partners of Rac1 in pancreatic β-cells: Evidence for increased interaction with Rac1 under hyperglycemic conditions.定量蛋白质组学揭示了 Rac1 在胰腺β细胞中的新相互作用伙伴:高血糖条件下与 Rac1 相互作用增加的证据。
Mol Cell Endocrinol. 2019 Aug 20;494:110489. doi: 10.1016/j.mce.2019.110489. Epub 2019 Jun 13.
10
Role of adipocyte mitochondria in inflammation, lipemia and insulin sensitivity in humans: effects of pioglitazone treatment.脂肪细胞线粒体在人类炎症、脂血症和胰岛素敏感性中的作用:吡格列酮治疗的效果
Int J Obes (Lond). 2017 Aug 14. doi: 10.1038/ijo.2017.192.

本文引用的文献

1
Proteomics: a pragmatic perspective.蛋白质组学:务实的视角。
Nat Biotechnol. 2010 Jul;28(7):695-709. doi: 10.1038/nbt.1658. Epub 2010 Jul 9.
2
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.内质网应激与代谢性疾病的炎症基础。
Cell. 2010 Mar 19;140(6):900-17. doi: 10.1016/j.cell.2010.02.034.
3
Streamlined analysis schema for high-throughput identification of endogenous protein complexes.高通量鉴定内源性蛋白质复合物的简化分析方案。
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2431-6. doi: 10.1073/pnas.0912599106. Epub 2010 Jan 22.
4
Revealing novel telomere proteins using in vivo cross-linking, tandem affinity purification, and label-free quantitative LC-FTICR-MS.使用体内交联、串联亲和纯化和无标记定量 LC-FTICR-MS 揭示新型端粒蛋白。
Mol Cell Proteomics. 2010 Jun;9(6):1144-56. doi: 10.1074/mcp.M900490-MCP200. Epub 2010 Jan 22.
5
Use of a label-free quantitative platform based on MS/MS average TIC to calculate dynamics of protein complexes in insulin signaling.使用基于串联质谱平均总离子流的无标记定量平台来计算胰岛素信号传导中蛋白质复合物的动态变化。
J Biomol Tech. 2009 Dec;20(5):272-7.
6
Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.骨骼肌胰岛素抵抗是2型糖尿病的主要缺陷。
Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S157-63. doi: 10.2337/dc09-S302.
7
Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes.人类骨骼肌蛋白质组学分析揭示肥胖症和 2 型糖尿病的新异常。
Diabetes. 2010 Jan;59(1):33-42. doi: 10.2337/db09-0214. Epub 2009 Oct 15.
8
Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance.Grp78 杂合性促进适应性未折叠蛋白反应,并减轻饮食诱导的肥胖和胰岛素抵抗。
Diabetes. 2010 Jan;59(1):6-16. doi: 10.2337/db09-0755. Epub 2009 Oct 6.
9
Quantitative interaction proteomics using mass spectrometry.使用质谱法的定量相互作用蛋白质组学。
Nat Methods. 2009 Mar;6(3):203-5. doi: 10.1038/nmeth.1302. Epub 2009 Feb 8.
10
The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2.胰岛素受体家族及其底物IRS-1和IRS-2的磷酸酪氨酸相互作用组。
Mol Cell Proteomics. 2009 Mar;8(3):519-34. doi: 10.1074/mcp.M800407-MCP200. Epub 2008 Nov 11.